$127.00
A weekly low-dose testosterone injection for women that may help support libido, energy, and overall wellbeing. Requires recent lab work. Monthly supply.
Prescription treatments include a short medical intake at checkout. A licensed clinician reviews every order before anything is prescribed or shipped — if it is not approved, you are fully refunded.
Women's testosterone therapy is only prescribed to patients with documented low testosterone or specific hormonal symptoms confirmed by lab work, who are already on estradiol and progesterone therapy. We recommend getting the lab work done PRIOR to ordering.
To Start: You'll need recent blood work (within the last 12 months) drawn between 7am and 10am, including a CMP and CBC. If you don't have recent labs, you can order our Women's TRT Initial Panel for a low cost.
To Continue After 90 Days: To monitor your response and ensure your testosterone stays within the appropriate range for women, you will need to complete a lab test within the first 90 days of using testosterone therapy. You can order our Women's TRT Maintenance Panel or complete it independently. The lab test must include the following biomarkers: CMP, CBC, TSH, Free T4, Testosterone (free and total), Estradiol, LH and FSH, SHBG, DHEA, Sulfate, Progesterone, Cortisol serum AM, and Vitamin D. Annually: After the 90-day check in, the Women's TRT Maintenance Panel will be required annually.
A note on injections
Because women use a much smaller dose than men, your dose is small and precisely measured, and your clinician will guide you through technique and rotating injection sites. Unlike topical options, there's no medication on the skin afterward, so there's no risk of transferring it to partners or children. Your care team can answer any questions about safe self-injection.
A note on what testosterone therapy is and isn't
Testosterone therapy for women is a medical treatment for symptoms tied to low testosterone, not a performance enhancer or general wellness treatment. Testosterone given to women who don't have low levels does not improve energy or libido and carries real risks, including effects on hair, skin, and voice. Your clinician will only prescribe testosterone if your labs and symptoms support a clinical need, and will monitor to keep levels within the appropriate range for women.
Testosterone is a prescription medication and a controlled substance in the United States, requiring evaluation by a licensed clinician.
Testosterone therapy for women is not FDA-approved. The FDA-approved versions of testosterone are dosed for men; testosterone for women is prescribed off-label, based on a growing body of clinical experience and international clinical guidelines. The Global Consensus Position Statement on Testosterone Therapy for Women, endorsed by major medical societies, supports testosterone use specifically for hypoactive sexual desire disorder (HSDD) in postmenopausal women.
Clinical guidelines often recommend topical testosterone as a first-line option for women. Injectable testosterone is also used and may suit women who prefer a weekly routine over daily application. Your clinician will help you choose the delivery method that fits you best.
This medication is compounded, meaning it's custom-prepared by a state-licensed pharmacy at doses specifically formulated for women.
Testosterone therapy for women is dosed to maintain physiologic female testosterone levels, not to raise levels above the normal female range.
Possible side effects include acne, oily skin, unwanted hair growth, and, with sustained high levels, changes to voice or skin that may not fully reverse. Your clinician will monitor for these and adjust your plan if needed.
Not everyone is a candidate. Your clinician will review your medical history, possible side effects, and whether this treatment is right for you.
Results vary and are not guaranteed.
Medications sourced from 503A and 503B U.S.-licensed pharmacies.
Lab testing conducted through CLIA-certified laboratories.
Care delivered by board-certified clinicians.
Available in all 50 states and Washington, D.C.